UniProtKB/Swiss-Prot P13804 : Variant p.Gly116Arg
Electron transfer flavoprotein subunit alpha, mitochondrial
Gene: ETFA
Feedback ?
Variant information
Variant position:
116
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glycine (G) to Arginine (R) at position 116 (G116R, p.Gly116Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In GA2A; impaired protein stability and loss of electron transfer activity.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
116
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
333
The length of the canonical sequence.
Location on the sequence:
ILATQKQFNYTHICAGASAF
G KNLLPRVAAKLEVAPISDII
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ILATQ-----KQFNYTHICAGASAFG KNLLPRVAAKLEVAPISDII
Mouse ILETQ-----KQFSYTHICAGASAFG KNLLPRVAAKLNVAP
Rat ILETQ-----KQFSYTHICAGASAFG KNLLPRVAAKLNVAP
Bovine ILATQ-----KQFNHTHICAGASAFG KNLLPRIAAKLDVAP
Caenorhabditis elegans ILASQ-----KQFNFTAITAGSSAFG RGVIPRVAAKLDVSS
Slime mold IVKLQSSSSKEGDEITHIFTPASNFG KNFLPRVAALLNVSQ
Baker's yeast LVKLL-----KGGDYSHFVVSNSSVG KSVLPRVGALLDVQP
Fission yeast LFENV-----KKNEISHVFSAHSTVG KGVMPRLAAMFDVMQ
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
20 – 333
Electron transfer flavoprotein subunit alpha, mitochondrial
Region
20 – 204
Domain I
Modified residue
101 – 101
N6-acetyllysine
Helix
114 – 127
Literature citations
Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients.
Freneaux E.; Sheffield V.C.; Molin L.; Shires A.; Rhead W.;
J. Clin. Invest. 90:1679-1686(1992)
Cited for: VARIANTS GA2A ARG-116 AND MET-266; FUNCTION; CHARACTERIZATION OF VARIANT GA2A MET-266;
Expression and characterization of two pathogenic mutations in human electron transfer flavoprotein.
Salazar D.; Zhang L.; deGala G.D.; Frerman F.E.;
J. Biol. Chem. 272:26425-26433(1997)
Cited for: CHARACTERIZATION OF VARIANTS GA2A ARG-116 AND MET-266; FUNCTION; COFACTOR; SUBUNIT;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.